CTOs on the Move

TriNetX

www.trinetx.com

 
TriNetX is the global health research network enabling healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. TriNetX combines EMR data such as demographics, diagnoses, procedures, medications, labs, genomics, and deep oncology data with data derived from clinical documentation including discharge summaries, radiology reports, pathology reports, and others, to deliver the industry`s most comprehensive data set for protocol design, feasibility, site selection and patient identification.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.trinetx.com
  • 125 Cambridgepark Drive Suite 500
    Cambridge, MA USA 02140
  • Phone: 857.285.6037

Executives

Name Title Contact Details
Matthew Matturro
 Senior Director, Information Security Profile
Steven Kundrot
 Chief Technology Officer Profile

Funding

TriNetX raised $40M on 03/13/2019

Similar Companies

Tarcine

Tarcine is a Thousand Oaks, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oncocyte

Oncocyte’s mission is to provide tests to physicians and patients that provide answers at critical decision points during lung cancer diagnosis.

INVO Bioscience

INVO Bioscience is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our INVOcell® Culture Device is a patented medical device used in the treatment of infertility that enables egg fertilization and early embryo development to take place in the woman`s body, in vivo. This revolutionary device promotes in vivo conception. It is an FDA cleared Intravaginal Culture (IVC) device that is a safe, effective and economical fertility treatment.

zacharon

zacharon is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BenevolentAI

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange.